Insider Trading March 30, 2026

RENN Fund President Murray Stahl Adds 1,134 RCG Shares in Late-March Purchase

Stahl increases direct holdings and acquires additional shares indirectly as RCG trades near its 52-week high

By Marcus Reed RCG
RENN Fund President Murray Stahl Adds 1,134 RCG Shares in Late-March Purchase
RCG

Murray Stahl, President and Co-Portfolio Manager of RENN Fund, Inc. (EXCHANGE: RCG), purchased 1,134 shares of common stock on March 27, 2026, at $3.25 per share. The buys came as the stock traded close to its 52-week peak and follows recent positive returns for the company, according to InvestingPro data.

Key Points

  • Murray Stahl bought 1,134 RCG shares on March 27, 2026, at $3.25 per share.
  • The stock was trading near its 52-week high of $3.31 and has risen about 28% over the past six months.
  • Stahl directly bought 360 shares and holds 158,534 shares directly after the transactions; additional shares were acquired indirectly through a spouse and several entities.

Murray Stahl, who serves as President and Co-Portfolio Manager of RENN Fund, Inc. (EXCHANGE: RCG), completed a set of purchases on March 27, 2026, acquiring 1,134 shares of the company's common stock at a reported price of $3.25 per share.

The transactions were executed while the stock was trading near a 52-week high of $3.31. Over the previous six months, RCG shares have appreciated roughly 28%.

All reported purchases were made at $3.25 per share and the reported total consideration for the aggregated transactions was $3,685. Of the total 1,134-share position, Stahl directly purchased 360 shares. The remainder of the position was obtained indirectly through several related parties, including his spouse, Fromex Equity Corp., FRMO Corp., Horizon Common Inc., Horizon Kinetics Hard Assets LLC and Horizon Kinetics Asset Management LLC.

After these trades, Stahl is documented as directly holding 158,534 shares of RCG common stock. The record also notes that he retains additional indirect holdings through his spouse and the other entities listed above.

Investor-oriented data reported by InvestingPro indicates that RCG has produced strong returns in the recent period and remained profitable over the last twelve months. The InvestingPro reference also notes that platform users can view six additional ProTips and a wider set of financial metrics for the company.


Contextual note: The details in this report are based on the transactions and data points provided. The article refrains from conjecture beyond the reported purchases, ownership totals and the InvestingPro summary of recent returns and profitability.

Risks

  • Limited detail on the precise split of indirect ownership - the article notes indirect holdings via a spouse and multiple entities but does not quantify those allocations (affects investor understanding of total beneficial ownership).
  • Market price context - RCG was trading close to its 52-week high at the time of the purchases, which is a factual state that may influence investor interpretation of future price movement (impacts market and financial sectors).

More from Insider Trading

Spyre Therapeutics CFO Disposes $370K in Stock, Exercises Options Same Day as Trial Timelines Accelerate Apr 3, 2026 Fold Holdings CEO completes modest stock sale to cover RSU tax obligations Apr 3, 2026 Spyre Therapeutics CEO Executes $739,912 Stock Sale as Trials Accelerate Apr 3, 2026 Spyre Therapeutics CMO Sells Shares, Exercises Options as Trials Accelerate Apr 3, 2026 Fold CFO Sells Small Stake to Meet Tax Withholding as Company Faces Revenue Shortfall Apr 3, 2026